BURLINGTON, N.C. – After lower-than-expected revenue forecasts, LabCorp is making some changes at the top, releasing the CEO of one of its two divisions.

Gary M. Huff, chief executive officer of LabCorp Diagnostics, and the Burlington-based global life sciences company “agreed that Mr. Huff’s employment with the company would terminate effective December 31, 2018,” according to a recent filing with the U.S. Securities and Exchange Commission.

David P. King, the company’s chairman and chief executive officer, will take over Huff’s role on an interim basis.

The complete terms of his separation package are “under negotiation”.

The reshuffle comes after a rocky few months for the company. A ransomware attack in July, coupled with the fallout from Hurricane Florence, sent LabCorp’s profits tumbling. As a result, its stock took a hit.

Back in October, LabCorp cut earnings by “approximately” 10 cents a share to $2.74. In turn, the company adjusted downward its guidance on earnings of the year by 10 cents a share.

LabCorp: Ransomware attack, hurricane cut profits by 10%; stock tumbles 4,4%

In other news, the company also announced that Edward T. Dodson, its senior vice president and chief accounting officer (CAO), will retire in April 2019.

Meanwhile, Peter Wilkinson will join the company as senior vice president of Accounting in early January and will assume the role of CAO upon Dodson’s retirement.

Prior to this appointment, Wilkinson, 48, served as executive vice president and chief financial officer of Syneos Health, Inc.’s Clinical Division, a biopharmaceuticals services organization, and as senior vice president and chief accounting officer of INC Research Holdings, Inc., a publicly traded predecessor to Syneos Health.